VALIPHARMA LIMITED
Research and experimental development on biotechnology
VALIPHARMA LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Stonebridge House Chelmsford Road Hatfield Heath CM22 7BD England
Full company profile for VALIPHARMA LIMITED (05085935), an active company based in Hatfield Heath, England. Incorporated 26 Mar 2004. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Cash in Bank
N/A
Net Assets
-£2.24M
Total Liabilities
£2.55M
Turnover
N/A
Employees
N/A
Debt Ratio
825%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Desler, Gerry | Director | British | United Kingdom | 3 Oct 2006 | Active |
See all 10 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (2)
Valirx Plc
United Kingdom
- Ownership Of Shares 25 To 50 Percent
Valibioinnovation Limited
United Kingdom
- Ownership Of Shares 50 To 75 Percent
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 27 Mar 2026 | Confirmation Statement | Confirmation statement made on 26 Mar 2026 with no updates | |
| 18 Jan 2026 | Officers | Appointment of Dr Mark Edward Eccleston as director on 18 Jan 2026 | |
| 12 Aug 2025 | Other | Notice of agreement to exemption from audit of accounts for period ending 31/12/24 | |
| 12 Aug 2025 | Other | Audit exemption statement of guarantee by parent company for period ending 31/12/24 | |
| 12 Aug 2025 | Accounts | Annual accounts filed |
Confirmation statement made on 26 Mar 2026 with no updates
Appointment of Dr Mark Edward Eccleston as director on 18 Jan 2026
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
Audit exemption statement of guarantee by parent company for period ending 31/12/24
Annual accounts filed
Recent Activity
Latest Activity
Confirmation statement made on 26 Mar 2026 with no updates
1 months ago on 27 Mar 2026
Appointment of Dr Mark Edward Eccleston as director on 18 Jan 2026
3 months ago on 18 Jan 2026
Notice of agreement to exemption from audit of accounts for period ending 31/12/24
8 months ago on 12 Aug 2025
Audit exemption statement of guarantee by parent company for period ending 31/12/24
8 months ago on 12 Aug 2025
Annual accounts filed
8 months ago on 12 Aug 2025